BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35668355)

  • 1. Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Zhang X; Huang WJ; Zhang ML; Wang W; Niu Y; Wang RT; Liu ZY
    BMC Gastroenterol; 2022 Jun; 22(1):288. PubMed ID: 35668355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
    Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 4. A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Wang M; Gao Y; Feng H; Warner E; An M; Jia J; Chen S; Fang M; Ji J; Gu X; Gao C
    Cancer Med; 2018 Mar; 7(3):646-654. PubMed ID: 29473340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
    Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum N-glycan fingerprint helps to discriminate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Huang C; Xu X; Wang M; Xiao X; Cheng C; Ji J; Fang M; Gao C
    Electrophoresis; 2021 Jun; 42(11):1187-1195. PubMed ID: 33570803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Chen J; Zhang W; Bao J; Wang K; Zhao Q; Zhu Y; Chen Y
    Abdom Radiol (NY); 2024 Jan; 49(1):93-102. PubMed ID: 37999743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
    Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
    World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
    J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.
    Huang JL; Sun Y; Wu ZH; Zhu HJ; Xia GJ; Zhu XS; Wu JH; Zhang KH
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10161-10168. PubMed ID: 37268850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors.
    Ainora ME; Cerrito L; Liguori A; Mignini I; De Luca A; Galasso L; Garcovich M; Riccardi L; Ponziani F; Santopaolo F; Pompili M; Gasbarrini A; Zocco MA
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Choi SY; Kim YK; Min JH; Kang TW; Jeong WK; Ahn S; Won H
    Eur Radiol; 2018 Jun; 28(6):2549-2560. PubMed ID: 29335868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value.
    Sheng R; Yang C; Zhang Y; Wang H; Zheng B; Han J; Sun W; Zeng M
    Radiol Med; 2023 Sep; 128(9):1047-1060. PubMed ID: 37474663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
    Zhou XD; Tang ZY; Fan J; Zhou J; Wu ZQ; Qin LX; Ma ZC; Sun HC; Qiu SJ; Yu Y; Ren N; Ye QH; Wang L; Ye SL
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1073-80. PubMed ID: 19294418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study.
    Wang S; Yao J; Li K; Yang H; Lu S; He G; Wu W; Cheng W; Jiang T; Ding H; Jing X; Yan Y; Liu F; Yu J; Han Z; Cheng Z; Tan S; Li X; Dou J; Li Y; Qi E; Zhang Y; Liang P; Yu X
    Abdom Radiol (NY); 2023 Oct; 48(10):3101-3113. PubMed ID: 37436451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CT and MR imaging differences between intrahepatic cholangiocarcinoma and hepatocellular carcinoma with invasions to billary tracts].
    Yang NJ; Song B; Wu B; Xu J; Zhao LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):525-8. PubMed ID: 19627020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravoxel incoherent motion diffusion-weighted imaging to differentiate hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Peng J; Zheng J; Yang C; Wang R; Zhou Y; Tao YY; Gong XQ; Wang WC; Zhang XM; Yang L
    Sci Rep; 2020 May; 10(1):7717. PubMed ID: 32382050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
    Zhou Q; Cai H; Xu MH; Ye Y; Li XL; Shi GM; Huang C; Zhu XD; Cai JB; Zhou J; Fan J; Ji Y; Sun HC; Shen YH
    Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):13-20. PubMed ID: 33160852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.